ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,321.41
0.25%
US Tech 100
18,213.20
-0.10%
다우존스 지수
39,872.99
0.17%
Bitcoin
70,039.73
-0.13%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Aerovate Therapeutics Inc (AVTE)

  7. Aerovate Therapeutics Inc (AVTE) 뉴스

AVTE

Aerovate Therapeutics (AVTE)

Aerovate Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVTE
일자시간출처헤드라인심볼기업
2024/05/2205:15GlobeNewswire Inc.Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
2024/05/1808:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/05/1805:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/05/1405:57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTEAerovate Therapeutics Inc
2024/05/1405:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
2024/05/1405:30GlobeNewswire Inc.Aerovate Therapeutics Announces First Quarter Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
2024/03/2722:20GlobeNewswire Inc.Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
2024/03/2605:10GlobeNewswire Inc.Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
2024/03/1207:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/03/0806:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/03/0622:00GlobeNewswire Inc.Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board ChairNASDAQ:AVTEAerovate Therapeutics Inc
2024/02/2808:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/02/2308:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/02/2108:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/02/1006:28Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/2508:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/2508:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/2508:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/2508:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/1806:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/0907:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVTEAerovate Therapeutics Inc
2024/01/0821:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/3008:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/2807:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/2308:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/2106:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/1608:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/1506:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/12/0808:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
2023/11/3008:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
 검색 관련기사 보기:NASDAQ:AVTE

최근 히스토리

AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
COIN
ETHUSD
Ethereum
FX
USDEUR
US Dollar vs Euro
CCOM
US500
US 500
NYSE
NKE
Nike
NYSE
AXP
American Express
AMEX
XLE
Energy Select Sector SPDR
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유